Chen Y - Search Results

1

Screening and Identification of Key Biomarkers for Bladder Cancer: A Study Based on TCGA and GEO Data.

Xu Y, Wu G, Li J, Li J, Ruan N, Ma L, Han X, Wei Y, Li L, Zhang H, Chen Y, Xia Q. Xu Y, et al. Among authors: chen y. Biomed Res Int. 2020 Jan 23;2020:8283401. doi: 10.1155/2020/8283401. eCollection 2020. Biomed Res Int. 2020. PMID: 32047816 Free PMC article.

2

Valproic acid (VPA) inhibits the epithelial-mesenchymal transition in prostate carcinoma via the dual suppression of SMAD4.

Lan X, Lu G, Yuan C, Mao S, Jiang W, Chen Y, Jin X, Xia Q. Lan X, et al. Among authors: chen y. J Cancer Res Clin Oncol. 2016 Jan;142(1):177-85. doi: 10.1007/s00432-015-2020-4. Epub 2015 Jul 24. J Cancer Res Clin Oncol. 2016. PMID: 26206483

3

Immunotherapy of DC-CIK cells enhances the efficacy of chemotherapy for solid cancer: a meta-analysis of randomized controlled trials in Chinese patients.

Lan XP, Chen YG, Wang Z, Yuan CW, Wang GG, Lu GL, Mao SW, Jin XB, Xia QH. Lan XP, et al. J Zhejiang Univ Sci B. 2015 Sep;16(9):743-56. doi: 10.1631/jzus.B1500003. J Zhejiang Univ Sci B. 2015. PMID: 26365116 Free PMC article.

4

Valproic acid inhibits epithelial‑mesenchymal transition in renal cell carcinoma by decreasing SMAD4 expression.

Mao S, Lu G, Lan X, Yuan C, Jiang W, Chen Y, Jin X, Xia Q. Mao S, et al. Among authors: chen y. Mol Med Rep. 2017 Nov;16(5):6190-6199. doi: 10.3892/mmr.2017.7394. Epub 2017 Aug 29. Mol Med Rep. 2017. PMID: 28901475

5

Valproic acid sensitizes metformin-resistant human renal cell carcinoma cells by upregulating H3 acetylation and EMT reversal.

Wei M, Mao S, Lu G, Li L, Lan X, Huang Z, Chen Y, Zhao M, Zhao Y, Xia Q. Wei M, et al. Among authors: chen y. BMC Cancer. 2018 Apr 17;18(1):434. doi: 10.1186/s12885-018-4344-3. BMC Cancer. 2018. PMID: 29665787 Free PMC article.

6

Long noncoding RNA SNHG16 contributes to the development of bladder cancer via regulating miR-98/STAT3/Wnt/β-catenin pathway axis.

Feng F, Chen A, Huang J, Xia Q, Chen Y, Jin X. Feng F, et al. Among authors: chen a, chen y. J Cell Biochem. 2018 Nov;119(11):9408-9418. doi: 10.1002/jcb.27257. Epub 2018 Aug 21. J Cell Biochem. 2018. Retraction in: J Cell Biochem. 2021 Nov;122 Suppl 1:S23. doi: 10.1002/jcb.29982 PMID: 30132983 Retracted.

7

Porcupine Inhibitor LGK974 Downregulates the Wnt Signaling Pathway and Inhibits Clear Cell Renal Cell Carcinoma.

Li J, Wu G, Xu Y, Li J, Ruan N, Chen Y, Zhang Q, Xia Q. Li J, et al. Among authors: chen y. Biomed Res Int. 2020 Feb 13;2020:2527643. doi: 10.1155/2020/2527643. eCollection 2020. Biomed Res Int. 2020. PMID: 32104684 Free PMC article.

8

TRIM33 Overexpression Inhibits the Progression of Clear Cell Renal Cell Carcinoma In Vivo and In Vitro.

Xu Y, Wu G, Zhang J, Li J, Ruan N, Zhang J, Zhang Z, Chen Y, Zhang Q, Xia Q. Xu Y, et al. Among authors: chen y. Biomed Res Int. 2020 Aug 25;2020:8409239. doi: 10.1155/2020/8409239. eCollection 2020. Biomed Res Int. 2020. PMID: 32908919 Free PMC article.

9

Folliculin deficient renal cancer cells exhibit BRCA1 A complex expression impairment and sensitivity to PARP1 inhibitor olaparib.

Zhang Q, Xu Y, Zhang Z, Li J, Xia Q, Chen Y. Zhang Q, et al. Among authors: chen y. Gene. 2021 Feb 15;769:145243. doi: 10.1016/j.gene.2020.145243. Epub 2020 Oct 16. Gene. 2021. PMID: 33069804

10

Genetic alteration and clinical significance of SUMOylation regulators in multiple cancer types.

Wu G, Xu Y, Ruan N, Li J, Lv Q, Zhang Q, Chen Y, Wang Q, Xia Q, Li Q. Wu G, et al. Among authors: chen y. J Cancer. 2020 Sep 30;11(23):6823-6833. doi: 10.7150/jca.49042. eCollection 2020. J Cancer. 2020. PMID: 33123273 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

180,525 results

Search Page

Filters